Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VASOPRESSIN Cause Electrocardiogram qt prolonged? 39 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Electrocardiogram qt prolonged have been filed in association with VASOPRESSIN (Vasopressin). This represents 2.0% of all adverse event reports for VASOPRESSIN.

39
Reports of Electrocardiogram qt prolonged with VASOPRESSIN
2.0%
of all VASOPRESSIN reports
27
Deaths
31
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From VASOPRESSIN?

Of the 39 reports, 27 (69.2%) resulted in death, 31 (79.5%) required hospitalization, and 11 (28.2%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VASOPRESSIN. However, 39 reports have been filed with the FAERS database.

What Other Side Effects Does VASOPRESSIN Cause?

Drug ineffective (1,018) Off label use (312) Cardiogenic shock (305) Multiple organ dysfunction syndrome (277) Condition aggravated (251) Hypotension (241) Hyponatraemia (235) Vomiting (233) Sepsis (230) Abdominal pain (221)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which VASOPRESSIN Alternatives Have Lower Electrocardiogram qt prolonged Risk?

VASOPRESSIN vs VECTIBIX VASOPRESSIN vs VECURONIUM VASOPRESSIN vs VEDOLIZUMAB VASOPRESSIN vs VELAGLUCERASE ALFA VASOPRESSIN vs VELCADE

Related Pages

VASOPRESSIN Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged VASOPRESSIN Demographics